Biocon signs out-licencing pact with Yoshindo
HQ Team October 17, 2022: Biocon Biologics, a subsidiary of India’s Biocon, has inked an out-licencing pact with Japan’s Yoshindo Inc for selling
HQ Team October 17, 2022: Biocon Biologics, a subsidiary of India’s Biocon, has inked an out-licencing pact with Japan’s Yoshindo Inc for selling
The global response to combat the Covid-19 crisis lacked cooperation and coordination: WHO
HQ team October 12, 2022: Marksans Pharma, a listed company, is set to acquire a manufacturing site of Tevapharm, an Indian subsidiary of
Cipla, an Indian pharmaceutical company, has joined the World Economic Forum’s Lighthouse network to adopt advanced fourth-industrial revolution technologies to transform operations digitally.
HT team October 11, 2022: More than half of the world’s poorest people, living in 54 developing economies, need urgent debt relief due
HT team October 11, 2022: The Competition Commission of India, the country’s anti-trust regulator has given the nod for Platinum Owl to buy
The EC has intimated Teva Pharmaceutical Industries, an Israel-based global company, of its "preliminary view" that it has breached EU antitrust rules by
COVID-19 vaccine maker BioNTech inks research deal with Australia
Four young Indian receive top honor for contributions to solving environmental problems
Study finds Earth-like habitable planets less